Challenges in the management of delirium: a case of augmentation with donepezil following inadequate response and adverse effects with risperidone.
Department of Psychiatry and Psychotherapy, University Hospital Zurich, Ramistrasse 100, 8091 Zurich, Switzerland, Lea.Stocker@usz.ch.
Lea
L
Stocker
Lena
L
Jellestad
Josef
J
Jenewein
Soenke
S
Boettger
D064807:Anticholinergic Syndrome / Q000188:drug therapy / Q000209:etiology; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects; D001712:Biperiden / Q000008:administration & dosage / Q000009:adverse effects*; D002056:Burns / Q000150:complications / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage; D003693:Delirium / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000523:psychology; D003937:Diagnosis, Differential; D000077265:Donepezil; D004333:Drug Administration Routes; D004357:Drug Synergism; D006801:Humans; D007189:Indans / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009127:Muscle Rigidity / Q000139:chemically induced / Q000188:drug therapy; D010830:Physostigmine / Q000008:administration & dosage*; D010880:Piperidines / Q000008:administration & dosage*; D018967:Risperidone / Q000008:administration & dosage / Q000009:adverse effects*; D016896:Treatment Outcome
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D007189:Indans; D010880:Piperidines; D001712:Biperiden; D000077265:Donepezil; D010830:Physostigmine; D018967:Risperidone